SCHEMBL9938525

SCHEMBL9938525

COS(=O)(=O)[O-].C[N+]1(C)CCN(c2ncc([N+](=O)[O-])cc2[N+](=O)[O-])CC1

nearest known ligand 0.58

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.33
ALDH1A1 P00352 3/20 0.58
HTT P42858 2/20 0.58
MAPK1 P28482 1/20 0.58
OPRK1 P41145 3/20 0.41
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 1/20 0.37
MAPT P10636 3/20 0.37
HSD11B1 P28845 1/20 0.36
CXCR3 P49682 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
JAK2 O60674 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
BACE1 P56817 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9974730 0.91 ALDH1A1 (0.70) ALDH1A1HTTMAPK1OPRK1CYP1A2
SCHEMBL15545367 0.79 MAPT (0.57) ALDH1A1HTTMAPK1CYP1A2CYP2C9
SCHEMBL9974756 0.77 ALDH1A1 (0.50) ALDH1A1HTTMAPK1OPRK1CYP1A2
SCHEMBL1093120 0.76 ALDH1A1 (0.97) ALDH1A1HTTMAPK1OPRK1CYP1A2
SCHEMBL1981534 0.75 ALDH1A1 (0.74) ALDH1A1HTTMAPK1CYP1A2CYP2C9
SCHEMBL4676953 0.75 ALDH1A1 (1.00) ALDH1A1HTTMAPK1OPRK1CYP1A2
SCHEMBL4679344 0.75 ALDH1A1 (1.00) ALDH1A1HTTMAPK1OPRK1CYP1A2
SCHEMBL5357980 0.74 SIRT6 (0.52) ALDH1A1MAPTHSD11B1LMNAPOLB
SCHEMBL14717627 0.74 OPRK1 (0.38) OPRK1
SCHEMBL4673638 0.73 ALDH1A1 (0.62) ALDH1A1HTTMAPK1OPRK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509951-B1 NOVEL CATIONIC AMINOPYRIDINES, DYE COMPOSITION COMPRISING A CATIONIC AMINOPYRIDINE, PROCESSES THEREFOR AND USES THEREOF ORÉAL L (FR) 2016-04-13 EP disclosed
US-9220671-B2 Dye composition comprising at least four dye precursors including at least one oxidation base and at least one coupler L'OREAL (FR) 2015-12-29 US disclosed
US-8491669-B2 Cationic 4-aminopyridine, dye composition comprising a cationic 4-aminopyridine, processes therefor and uses thereof L'OREAL (FR) 2013-07-23 US disclosed
US-20130048007-A1 NOVEL CATIONIC 4- AMINOINDOLES, DYE COMPOSITION COMPRISING A CATIONIC 4-AMINOINDOLE, PROCESSES THEREFOR AND USES THEREOF L'OREAL (FR) 2013-02-28 US disclosed
WO-2012080287-A2 DYE COMPOSITION COMPRISING A SECONDARY PARA-PHENYLENEDIAMINE OXIDATION BASE AND A CATIONIC 3,5-DIAMINOPYRIDINE COUPLER L'OREAL (FR) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048007-A1 NOVEL CATIONIC 4- AMINOINDOLES, DYE COMPOSITION COMPRISING A CATIONIC 4-AMINOINDOLE, PROCESSES THEREFOR AND USES THEREOF TPH1, ALDH7A1, FARS2 ACHE 4073/4885ALDH1A1 166/4885HTT 1342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.